PROPOSAL FORMAT

Nature of Promotional Expense: Bonus/Discount/Trade offer/Spl Rate/Factory Visit/CME/Speaker

Tour/Phase -IV /Travel/Conference sponsorships/patient support/ Others _________________________________

KOL /HOSPITAL/STOCKIST NAME: Dr Ravi Byahut

TYPE OF EXPENSE: Budgeted Expense

PROPOSAL DETAILS:
COST 24,186
DESCRIPTION Reimbursing Flight tickets of Dr's tour

PERIOD TO BE INCURRED (Q1/Q2/Q3/Q4) Q3

BUDGET FOR THIS PERIOD

YTD DETAILS (for both budgeted/non-budgeted):

PERIOD Q1 Q2 Q3 Q4 YTD
BUDGETED EXP
ACTUAL EXPENSE 24186
ACTUAL SALE 50000
SALE TO EXPENSE RATIO (% )

Proposed by (KAM name): Prashant Sinha

Approved by ZM/SM (With comments in case of New Proposal/ in case budget is exceeded):
Already approved in the old format

Approved by Marketing Manager (Rationale for approving proposal): A small lil' service like this
at this juncture will really give it a great impetus to the relationship and business.One of
the major KOLs for us in U.P.

A-VP/VP:

PRESIDENT/CEO:

*for new KOL proposal, fill annexure 1 and for INSTITUTE fill Annexure 2
KOL NAME Q1 Q1 Inv % Q2 BUSINESS Q2 Inv % Q3 Q3 Inv % Q4 BUSINESS Q4 Inv % TOTAL BUSINESS TOTAL %
BUSINESS BUSINES INV
S

Proposed by (KAM name):

Approved by ZM/SM (With comments in case of New Proposal/ in case budget is

exceeded):

Approved by Marketing Manager (With comments in case of New Proposal / in

case budget is exceeded):
 NAME OF INSTITUTE:
TOTAL SALES
Special Required Discount QUANTITY (UNITS) VALUE TOTAL SALES TOTAL
price per price per per unit 2010 ESTIMATED (in VALUE WITHOUT DISCOUNT (in
BRAND Strength unit (Rs.) unit (Rs.) (Rs.) Q1 Q2 Q3 Q4 (TOTAL) lac) DISCOUNT (in lac) lac)

Stritoxol 30 mg 891 891 0 0.00 0.00 0.00

Stritoxol 100 mg 1,736 1,736 0 0.00 0.00 0.00

Stritoxol 260 mg 4,481 4,481 0 0.00 0.00 0.00

Stridotere 20 mg 1,810 1,810 0 0.00 0.00 0.00

Stridotere 80 mg 6,307 6,307 0 0.00 0.00 0.00

Stridotere 120 mg 7,640 7,640 0 0.00 0.00 0.00

Soxplat 50 mg 1,346 1,346 0 0.00 0.00 0.00

Soxplat 100 mg 2,684 2,684 0 0.00 0.00 0.00

Stridevine 10 mg 1,902 1,902 0 0.00 0.00 0.00

Stridevine 50 mg 7,305 7,305 0 0.00 0.00 0.00

Stricyte 200 mg 913 913 0 0.00 0.00 0.00

Stricyte 1 gm 3,652 3,652 0 0.00 0.00 0.00

Stribicin 10 mg 354 354 0 0.00 0.00 0.00

Stribicin 50 mg 1,367 1,367 0 0.00 0.00 0.00

Stricarb 150 mg 561 561 0 0.00 0.00 0.00

Stricarb 450 mg 1,630 1,630 0 0.00 0.00 0.00

Stritin 10 mg 61 61 0 0.00 0.00 0.00

Stritin 50 mg 255 255 0 0.00 0.00 0.00

Stridox 10 mg 138 138 0 0.00 0.00 0.00

Stridox 50 mg 539 539 0 0.00 0.00 0.00

Stridabine 50 mg 6,854 6,854 0 0.00 0.00 0.00

Stritosar 40 mg 1,017 1,017 0 0.00 0.00 0.00

Stritosar 100 mg 2,036 2,036 0 0.00 0.00 0.00

Strizat 1 mg 339 339 0 0.00 0.00 0.00

Strimodal 20 mg 1,018 1,018 0 0.00 0.00 0.00

Strimodal 100 mg 4,581 4,581 0 0.00 0.00 0.00

Strimodal 250 mg 9,696 9,696 0 0.00 0.00 0.00

Stritinib 100 mg 609 609 0 0.00 0.00 0.00

Stritinib 400 mg 2,231 2,231 0 0.00 0.00 0.00

Stridessa 250 mg 6,592 6,592 0 0.00 0.00 0.00

Stricept 250 mg 350 350 0 0.00 0.00 0.00

Stricept 500 mg 659 659 0 0.00 0.00 0.00

Stridimmune 25 mg 99 99 0 0.00 0.00 0.00

Stridimmune 50 mg 198 198 0 0.00 0.00 0.00

Stridimmune 100 mg 375 375 0 0.00 0.00 0.00

Strimus 1 mg 583 583 0 0.00 0.00 0.00

Strigraf 0.5 mg 142 142 0 0.00 0.00 0.00

Strigraf 1 mg 279 279 0 0.00 0.00 0.00

TOTAL 0.00 0.00 0.00

Proposed by (KAM name):

Approved by ZM/SM (With comments in case of New Proposal/ in case budget is exceeded):

Approved by Marketing Manager (With comments in case of New Proposal / in case budget is exceeded):
Approved by Marketing Manager (With comments in case of New Proposal / in case budget is exceeded):
 NAME OF INSTITUTE:

% DISCOUNT ON
THIS PRODUCT

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

0%

se budget is exceeded):

roposal / in case budget is exceeded):

roposal / in case budget is exceeded):